home / stock / mgclf / mgclf quote
Last: | $0.26 |
---|---|
Change Percent: | 0.0% |
Open: | $0.26 |
Close: | $0.26 |
High: | $0.26 |
Low: | $0.26 |
Volume: | 356 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.26 | $0.26 | $0.26 | $0.26 | $0.26 | 356 | 05-01-2024 |
$0.28 | $0 | $0.28 | $0 | $0 | 2 | 04-29-2024 |
$0.28 | $0.28 | $0.28 | $0.28 | $0.28 | 1,000 | 04-26-2024 |
$0.256 | $0.256 | $0.256 | $0.256 | $0.256 | 511 | 04-24-2024 |
$0.27 | $0.27 | $0.27 | $0.27 | $0.27 | 2,500 | 04-19-2024 |
$0.26 | $0.26 | $0.26 | $0.26 | $0.26 | 460 | 04-16-2024 |
$0.28 | $0.28 | $0.28 | $0.28 | $0.28 | 470 | 04-15-2024 |
$0.28 | $0 | $0.28 | $0 | $0 | 4 | 04-09-2024 |
$0.28 | $0.28 | $0.28 | $0.28 | $0.28 | 2,500 | 04-05-2024 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.295 | 150 | 04-01-2024 |
$0.285 | $0.285 | $0.285 | $0.285 | $0.285 | 580 | 03-26-2024 |
$0.295 | $0 | $0.295 | $0 | $0 | 15 | 03-25-2024 |
$0.295 | $0 | $0.295 | $0 | $0 | 30 | 03-21-2024 |
$0.295 | $0 | $0.295 | $0 | $0 | 33 | 03-13-2024 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.295 | 100 | 03-06-2024 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.295 | 2,506 | 03-05-2024 |
$0.2458 | $0.2458 | $0.2458 | $0.2458 | $0.2458 | 700 | 02-27-2024 |
$0.278 | $0 | $0.278 | $0 | $0 | 7 | 02-23-2024 |
$0.278 | $0 | $0.278 | $0 | $0 | 5 | 02-22-2024 |
$0.278 | $0 | $0.278 | $0 | $0 | 25 | 02-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
MGC Pharmaceuticals Ltd Company Name:
MGCLF Stock Symbol:
OTCMKTS Market:
--News Direct-- Argent BioPharma managing director and CEO Roby Zomer speaks to Proactive's Stephen Gunnion following the company's rebranding from MGC Pharmaceuticals, alongside a comprehensive restructuring. Zomer explained the shift marks a refined focus on the pharmaceutical s...
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation PR Newswire Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma's Innovative Drug Portfolio LONDON , Feb. 13, 2024 /PRNe...
(NewsDirect) MGC Pharmaceuticals Ltd CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the future of th...